Loading ETF research
Fetching the latest fund profile, holdings, and market data.
Loading ETF research
Fetching the latest fund profile, holdings, and market data.

New York Stock Exchange ArcaEquity ETF
$162.05
−$6.33 · -3.76%
As of Oct 8, 3:59 PM ET
Regular session · ET · Market data may be delayed.
The ProShares Ultra Technology fund (ROM) endeavors to provide daily investment returns that accurately reflect double (2x) the daily performance of the S&P Technology Select SectorSM Index. This goal is measured prior to factoring in any fees or operational expenses.
Fund facts updated Oct 8, 2026.
Day range
Current $162.05
52-week range
Current $162.05
1 month
+10.18%
3 months
+15.49%
Year to date
+71.85%
1 year
+64.82%
3 years
+289.36%
5 years
+215.03%
Since inception
+7299.54%
Cumulative price changes exclude distributions and investor-specific taxes, trading costs, and cash flows.
Showing 15 of 84 reported holdings
Displayed portfolio weight: 79.69%
Holdings data updated Oct 8, 2026.
Portfolio weights show the assets held by the fund; they do not represent its leveraged or inverse market exposure.
Mar 25, 2026
Mar 25, 2026
Mar 31, 2026
$0.0228
Quarterly
Dec 24, 2025
Dec 24, 2025
Dec 31, 2025
$0.0162
Quarterly
Sep 24, 2025
Sep 24, 2025
Sep 30, 2025
$0.05
Quarterly
Jun 25, 2025
Jun 25, 2025
Jul 1, 2025
$0.141
Quarterly
Mar 26, 2025
Mar 26, 2025
Apr 1, 2025
$0.0172
Quarterly
Dec 23, 2024
Dec 23, 2024
Dec 31, 2024
$0.0347
Quarterly
Sep 25, 2024
Sep 25, 2024
Oct 2, 2024
$0.0621
Quarterly
Jun 26, 2024
Jun 26, 2024
Jul 3, 2024
$0.0381
Quarterly
Mar 20, 2024
Mar 21, 2024
Mar 27, 2024
$0.0107
Quarterly
Dec 20, 2023
Dec 21, 2023
Dec 28, 2023
$0.0042
Quarterly
Amounts are shown per share in the ETF trading currency and adjusted for splits when the provider supplies an adjusted value; otherwise the reported amount is used.
Continue in GoAI
Connect this ETF with broader market context and continue your research in GoAI.
ETF data may be delayed, incomplete, or revised. Holdings and exposures change over time. Historical performance does not guarantee future results. This page is for informational and educational purposes only and does not constitute investment advice or a recommendation.